GlassScriptPhysician profile
Jon Eric Chancellor
NPI 1598708794
$7,336.36
in general payments reported to CMS, 2019-2025
40 companies · $534 in 2025
The $534 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $2,034 · 2021: $915 · 2022: $1,624 · 2023: $808 · 2024: $603 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,428.89 | 2019-2024 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $1,165.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $946.82 | 2022-2023 | Iovera, Zilretta |
| Abbvie INC. | $638.02 | 2021-2025 | Vraylar, Qulipta |
| Daiichi Sankyo INC. | $585.65 | 2019-2025 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.66 | 2020-2025 | Xifaxan |
| Lilly USA, LLC | $273.42 | 2019-2025 | Jardiance, Mounjaro |
| Pfizer INC. | $211.11 | 2019-2024 | |
| Pacira Therapeutics, INC. | $185.14 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $166.01 | 2022-2025 | Zoryve, Seglentis, Livalo |
| Exact Sciences Corporation | $154.88 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $150.40 | 2020-2021 | |
| Almatica Pharma LLC | $138.65 | 2022-2023 | Gralise, Loreev Xr, Sertraline Hcl |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.87 | 2019-2024 | Synjardy, Jardiance |
| Novo Nordisk INC | $90.41 | 2019-2025 | Wegovy |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Chancellor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.